Literature DB >> 23850066

Menin: a scaffold protein that controls gene expression and cell signaling.

Smita Matkar1, Austin Thiel, Xianxin Hua.   

Abstract

The protein menin is encoded by the MEN1 gene, which is mutated in patients with multiple endocrine neoplasia type 1 (MEN1) syndrome. Although menin acts as a tumor suppressor in endocrine organs, it is required for leukemic transformation in mouse models. Menin possesses these dichotomous functions probably because it can both positively and negatively regulate gene expression, as well as interact with a multitude of proteins with diverse functions. Here, we review the recent progress in understanding the molecular mechanisms by which menin functions. The crystal structures of menin with different binding partners reveal that menin is a key scaffold protein that functionally crosstalks with various partners to regulate gene transcription and interplay with multiple signaling pathways.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cell signaling; gene transcription; menin; scaffold protein

Mesh:

Substances:

Year:  2013        PMID: 23850066      PMCID: PMC3741089          DOI: 10.1016/j.tibs.2013.05.005

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  94 in total

1.  Glucose-mediated repression of menin promotes pancreatic β-cell proliferation.

Authors:  Hongli Zhang; Wenyi Li; Qidi Wang; Xiao Wang; Fengying Li; Cuiping Zhang; Ling Wu; Hongmei Long; Yun Liu; Xiaoying Li; Min Luo; Guo Li; Guang Ning
Journal:  Endocrinology       Date:  2011-12-13       Impact factor: 4.736

2.  The regulatory network menin-microRNA 26a as a possible target for RNA-based therapy of bone diseases.

Authors:  Ettore Luzi; Francesca Marini; Isabella Tognarini; Gianna Galli; Alberto Falchetti; Maria Luisa Brandi
Journal:  Nucleic Acid Ther       Date:  2012-03-12       Impact factor: 5.486

3.  Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia.

Authors:  Jolanta Grembecka; Shihan He; Aibin Shi; Trupta Purohit; Andrew G Muntean; Roderick J Sorenson; Hollis D Showalter; Marcelo J Murai; Amalia M Belcher; Thomas Hartley; Jay L Hess; Tomasz Cierpicki
Journal:  Nat Chem Biol       Date:  2012-01-29       Impact factor: 15.040

4.  Menin critically links MLL proteins with LEDGF on cancer-associated target genes.

Authors:  Akihiko Yokoyama; Michael L Cleary
Journal:  Cancer Cell       Date:  2008-07-08       Impact factor: 31.743

Review 5.  Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast.

Authors:  G N Hendy; H Kaji; H Sowa; J-J Lebrun; L Canaff
Journal:  Horm Metab Res       Date:  2005-06       Impact factor: 2.936

6.  Menin expression is regulated by transforming growth factor beta signaling in leukemia cells.

Authors:  Hui Zhang; Zu-Guo Liu; Xian-Xin Hua
Journal:  Chin Med J (Engl)       Date:  2011-05       Impact factor: 2.628

7.  The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.

Authors:  Akihiko Yokoyama; Tim C P Somervaille; Kevin S Smith; Orit Rozenblatt-Rosen; Matthew Meyerson; Michael L Cleary
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

8.  Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.

Authors:  Gao Chen; Jingbo A; Min Wang; Steven Farley; Lung-Yi Lee; Lung-Ching Lee; Mark P Sawicki
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

9.  Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice.

Authors:  Philippe Bertolino; Wei-Min Tong; Pedro Luis Herrera; Huguette Casse; Chang Xian Zhang; Zhao-Qi Wang
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

10.  Nuclear-cytoplasmic shuttling of menin regulates nuclear translocation of {beta}-catenin.

Authors:  Yanan Cao; Ruixin Liu; Xiuli Jiang; Jieli Lu; Jingjing Jiang; Changxian Zhang; Xiaoying Li; Guang Ning
Journal:  Mol Cell Biol       Date:  2009-08-03       Impact factor: 4.272

View more
  83 in total

1.  Spatial Interplay between Polycomb and Trithorax Complexes Controls Transcriptional Activity in T Lymphocytes.

Authors:  Atsushi Onodera; Damon J Tumes; Yukiko Watanabe; Kiyoshi Hirahara; Atsushi Kaneda; Fumihiro Sugiyama; Yutaka Suzuki; Toshinori Nakayama
Journal:  Mol Cell Biol       Date:  2015-08-31       Impact factor: 4.272

2.  miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.

Authors:  Laurent Ehrlich; Chad Hall; Julie Venter; David Dostal; Francesca Bernuzzi; Pietro Invernizzi; Fanyin Meng; Jerome P Trzeciakowski; Tianhao Zhou; Holly Standeford; Gianfranco Alpini; Terry C Lairmore; Shannon Glaser
Journal:  Am J Pathol       Date:  2017-01-11       Impact factor: 4.307

Review 3.  Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies.

Authors:  Gitta Boons; Timon Vandamme; Marc Peeters; Guy Van Camp; Ken Op de Beeck
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

Review 4.  Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Mark Kidd; Irvin Modlin; Kjell Öberg
Journal:  Nat Rev Clin Oncol       Date:  2016-06-07       Impact factor: 66.675

5.  Neuron-Specific Menin Deletion Leads to Synaptic Dysfunction and Cognitive Impairment by Modulating p35 Expression.

Authors:  Kai Zhuang; Changquan Huang; Lige Leng; Honghua Zheng; Yuehong Gao; Guimiao Chen; Zhilin Ji; Hao Sun; Yu Hu; Di Wu; Meng Shi; Huifang Li; Yingjun Zhao; Yunwu Zhang; Maoqiang Xue; Guojun Bu; Timothy Y Huang; Huaxi Xu; Jie Zhang
Journal:  Cell Rep       Date:  2018-07-17       Impact factor: 9.423

Review 6.  Challenges and opportunities in targeting the menin-MLL interaction.

Authors:  Tomasz Cierpicki; Jolanta Grembecka
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

7.  Islet-specific Prmt5 excision leads to reduced insulin expression and glucose intolerance in mice.

Authors:  Jian Ma; Xin He; Yan Cao; Kienan O'Dwyer; Katherine M Szigety; Yuan Wu; Buddha Gurung; Zijie Feng; Bryson W Katona; Xianxin Hua
Journal:  J Endocrinol       Date:  2020-01-01       Impact factor: 4.286

Review 8.  Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?

Authors:  Michael S Lee; Bert H O'Neil
Journal:  J Gastrointest Oncol       Date:  2016-10

Review 9.  H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer.

Authors:  J N Nichol; D Dupéré-Richer; T Ezponda; J D Licht; W H Miller
Journal:  Adv Cancer Res       Date:  2016-06-17       Impact factor: 6.242

10.  Modulation by miR-29b of intestinal epithelium homoeostasis through the repression of menin translation.

Authors:  Miao Ouyang; Weijie Su; Lan Xiao; Jaladanki N Rao; Liping Jiang; Yanwu Li; Douglas J Turner; Myriam Gorospe; Jian-Ying Wang
Journal:  Biochem J       Date:  2015-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.